MONTGOMERY, Ala. (AP) — Brand-name drug makers can be held liable for warnings on a generic medication even if it was produced by another company, the Alabama Supreme Court ruled Friday, standing by an earlier decision that business leaders viewed as a defeat.
The all-Republican court was divided, with Chief Justice Roy Moore and two other members issuing dissents.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.